Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Champions Oncolog (CSBR)

4.1399 -0.02 (-0.48%)

05-22 10:34

Open:

4.15

Pre. Close:

4.16

High:

4.19

Low:

4.1399

Volume:

3,207

Market Cap:

46M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.232 - 4.26

4.26 - 4.284

Low:

4.105 - 4.133

4.133 - 4.156

Close:

4.119 - 4.164

4.164 - 4.202

Technical analysis  (as of: 2018-05-22 11:08:42 AM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 5.08     One year: 5.52

Support:

Support1: 3.73    Support2: 3.10

Resistance:

Resistance1: 4.35    Resistance2: 4.73

Pivot:

4.33

Moving Averages:

MA(5): 4.17     MA(20): 4.32

MA(100): 3.88     MA(250): 3.45

MACD:

MACD(12,26): 0.04     Signal(12,26,9): 0.09

%K %D:

%K(14,3): 4.99     %D(3): 8.39

RSI:

RSI(14): 47.62

52-Week:

High: 4.75  Low: 2.19  Change(%): 65.6

Average Vol(K):

3-Month: 2475  10-Days 687

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CSBR has closed above bottom band by 19.8%. Bollinger Bands are 0.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-03T08:30:00-04:00
Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th

2018-05-01T08:30:00-04:00
Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research

2018-04-04T08:30:00-04:00
Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House

2018-03-15T21:13:03-04:00
Champions Oncology's (CSBR) CEO Ronnie Morris on Q3 2018 Results - Earnings Call Transcript

2018-03-15T16:43:20-04:00
Champions Oncology reports Q3 results

2018-03-15T16:01:00-04:00
Champions Oncology Reports Quarterly Revenue of $5.1 Million

2018-03-07T08:30:00-05:00
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018

2018-02-26T08:30:00-05:00
Champions Oncology to Participate at the 30th Annual ROTH Conference

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

11.00

Shares Float (M)

% Held by Insiders

% Held by Institutions

38.00

Shares Short (K)

13

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

104.410

PEG Ratio

Profit Margin

-5.51

Operating Margin

Return on Assets (ttm)

-44.6

Return on Equity (ttm)

-260.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.04

P/S

27106490.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2015-08-12

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.